6β-Naltrexol, a Peripherally Selective Opioid Antagonist that Inhibits Morphine-Induced Slowing of Gastrointestinal Transit: An Exploratory Study
Janet E. Yancey-Wrona(University of Portland), Wolfgang Sadée(The Ohio State University), Edward J. Bilsky(Pacific Northwest University of Health Sciences), Lynn R. Webster(Adherent Technologies (United States)), Mitch A. Phelps(The Ohio State University), B.K. Dallaire, Xiaoxia Yang(The Ohio State University), Brad Bath(Rocky Mountain Multiple Sclerosis Clinic), John Burkart, Dan Magiera
Cited by 27
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory
|Proceedings of the National Academy of Sciences|2007|421
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309